Health News (Reuters)

Roche tests 'brain shuttle' in humans in Alzheimer's project

Roche is testing its "brain shuttle" in humans, with the Swiss drugmaker hoping to rejuvenate the theory that removing amyloid plaques from the brains of patients with Alzheimer's disease will prove effective despite repeated failures.

FDA rejects Lipocine's testosterone drug for third time

The U.S. Food and Drug Administration on Monday declined to approve Lipocine Inc's oral drug to treat a condition that results in lower production of male sex hormone for the third time, sending the drug developer's shares down 34%.

U.S. records one new case in measles outbreak

One new case of measles was reported this weekend in the United States, with the country suffering its worst outbreak of the highly contagious and sometimes deadly disease in close-to three decades.

Roche says SMA drug meets trial goal

Roche said on Monday its drug risdiplam helped people with type 2 or 3 spinal muscular atrophy improve their motor function, as the Swiss drugmaker presses ahead with a medicine it sees rivaling Biogen's Spinraza and Novartis's Zolgensma.

South Korea bans liquid e-cigarettes on army bases

The South Korean Army has banned the use and possession of liquid e-cigarettes on its bases for health reasons, the military said on Monday, following a government warning for people to stop using the devices.

Ben & Jerry's is sued over 'happy cows' claim

Ben & Jerry's has been sued by an environmental advocate who said it deceived consumers by touting that the milk and cream it uses to make ice cream came exclusively from "happy cows."

U.S. FDA approves Celgene's rare blood disorder drug

The U.S. Food and Drug Administration said on Friday it had approved a treatment for a rare blood disorder from Celgene Corp, which is in the process of being bought by Bristol-Myers Squibb Co.

Pages